What does remission mean for Ovarian Cancer and how is it monitored

Understanding Remission in Ovarian Cancer

What Remission Means

Remission in ovarian cancer refers to a state where the cancer is no longer detectable or has significantly decreased. There are two main types:

Complete Remission (CR): All signs and symptoms of cancer have disappeared based on imaging, blood tests, and physical exams. However, this doesn't necessarily mean the cancer is completely gone at the cellular level—some microscopic disease may remain.

Partial Remission (PR): The tumor has shrunk by at least 50%, but some cancer remains visible on scans or in blood markers.

It's important to understand that remission is different from a cure. Even in complete remission, ovarian cancer can potentially return, which is why ongoing monitoring is essential.

---

How Remission is Monitored

1. CA-125 Blood Marker

CA-125 is the primary biomarker used to monitor ovarian cancer. This is a protein that cancer cells often produce in higher amounts. Your oncologist will:

• Check your CA-125 levels regularly (typically every 3-6 months initially)
• Compare current levels to your baseline (your starting level)
• Look for trends—rising levels may suggest recurrence before it appears on imaging

What the numbers mean:

• Normal CA-125: typically less than 35 units/mL
• Declining levels during treatment = good response
• Rising levels in remission = potential warning sign

2. Imaging Studies

Your care team will use imaging at regular intervals:

• CT scans (computed tomography) - the standard imaging for ovarian cancer
• PET scans (positron emission tomography) - sometimes used to detect metabolic activity
• Ultrasound - may be used for follow-up of specific findings

These scans look for any new tumors or growth of existing ones.

3. Physical Examination

Your oncologist will perform regular physical exams to check for:

• Abdominal masses or swelling
• Fluid accumulation (ascites)
• Lymph node enlargement
• Other physical signs of disease

4. Circulating Tumor Cells (CTCs) - Emerging Technology

According to recent advances in personalized cancer monitoring, some centers are exploring circulating tumor cells as a more sensitive way to detect disease activity. As discussed in the CancerPatientLab webinar on "Novel Testing to Guide Personalized Cancer Treatment," CTCs can provide early warning of disease progression:

• Low CTC counts (0-1) = remission level with very low recurrence risk
• Rising CTC counts = potential sign of disease reactivation, even before imaging changes appear
• Phenotype markers (tumor stem cell markers) = important indicators of disease activity, sometimes more predictive than CTC numbers alone

This represents an emerging approach to monitoring that may catch recurrence earlier than traditional methods.

---

Monitoring Schedule

During active treatment: Frequent monitoring (every 4-8 weeks)

After completing treatment:

• Months 1-2: Every 4 weeks
• Months 3-12: Every 8-12 weeks
• Year 2+: Every 3-6 months (or as recommended by your oncologist)

The exact schedule depends on your specific situation, stage at diagnosis, and treatment response.

---

Important Questions to Ask Your Oncology Team

1. What is my current CA-125 level, and what was my baseline? Understanding your personal numbers helps you track trends.

2. How often will I have imaging scans, and what type? This helps you plan and understand what to expect.

3. What CA-125 level or imaging finding would suggest recurrence? Different patients have different thresholds based on their individual disease.

4. Are there any newer monitoring tests (like CTCs or cfDNA) that might be appropriate for my case? Emerging technologies may provide additional information.

5. What symptoms should I report between appointments? Knowing warning signs helps you stay proactive.

6. How long will I need monitoring, and what does long-term follow-up look like? Understanding the long-term plan helps with planning and peace of mind.

---

Key Takeaway

Remission is an important milestone in ovarian cancer treatment, but it requires ongoing vigilance. Your care team uses multiple tools—blood tests, imaging, physical exams, and increasingly, advanced biomarkers—to catch any signs of recurrence early. Regular monitoring appointments are not just routine; they're an essential part of your long-term care strategy.

According to the CancerPatientLab webinar on personalized cancer monitoring, the goal is to detect disease activity as early as possible, when treatment options are often most effective. This is why consistent follow-up, even when you're feeling well, is so important.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.